CVS Health Forecast, price target & analysts
CVS Health Target price 2025 - Analyst rating & recommendation
CVS Health Classifications & Recommendation:
CVS Health Price Target
| Target Price | $71.74 |
| Price | $64.84 |
| Potential |
10.64%
register free of charge
|
| Number of Estimates | 23 |
|
23 Analysts have issued a price target CVS Health 2026 .
The average CVS Health target price is $71.74.
This is
10.64%
register free of charge
$81.00
24.92%
register free of charge
$51.00
21.34%
register free of charge
|
|
| A rating was issued by 29 analysts: 19 Analysts recommend CVS Health to buy, 10 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the CVS Health stock has an average upside potential 2026 of
10.64%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2029
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Billion $ | 372.69 | 389.41 |
| 4.02% | 4.49% | |
| EBITDA Margin | 3.90% | 4.05% |
| 30.04% | 3.97% | |
| Net Margin | 1.24% | 1.47% |
| 45.62% | 18.80% |
22 Analysts have issued a sales forecast CVS Health 2025 . The average CVS Health sales estimate is
This results in the following potential growth metrics:
17 Analysts have issued an CVS Health EBITDA forecast 2025. The average CVS Health EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
13 CVS Health Analysts have issued a net profit forecast 2025. The average CVS Health net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 3.66 | 4.55 |
| 43.43% | 24.32% | |
| P/E | 14.24 | |
| EV/Sales | 0.39 |
13 Analysts have issued a CVS Health forecast for earnings per share. The average CVS Health <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2025, the CVS Health stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
Current CVS Health Upgrades & Downgrades Beta
| Analyst | Rating | Action | Date |
|---|---|---|---|
| JP Morgan |
Locked
➜
Locked
|
Locked | Feb 18 2025 |
| Truist Securities |
Locked
➜
Locked
|
Locked | Feb 13 2025 |
| Wells Fargo |
Locked
➜
Locked
|
Locked | Feb 13 2025 |
| Barclays |
Locked
➜
Locked
|
Locked | Feb 13 2025 |
| Leerink Partners |
Locked
➜
Locked
|
Locked | Feb 13 2025 |
| Evercore ISI Group |
Locked
➜
Locked
|
Locked | Jan 27 2025 |
| Truist Securities |
Locked
➜
Locked
|
Locked | Jan 06 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
JP Morgan:
Locked
➜
Locked
|
Feb 18 2025 |
|
Locked
Truist Securities:
Locked
➜
Locked
|
Feb 13 2025 |
|
Locked
Wells Fargo:
Locked
➜
Locked
|
Feb 13 2025 |
|
Locked
Barclays:
Locked
➜
Locked
|
Feb 13 2025 |
|
Locked
Leerink Partners:
Locked
➜
Locked
|
Feb 13 2025 |
|
Locked
Evercore ISI Group:
Locked
➜
Locked
|
Jan 27 2025 |
|
Locked
Truist Securities:
Locked
➜
Locked
|
Jan 06 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
